Exhale

The official blog of the Lung Institute.

What To Expect From COPD Awareness Month

5 Nov 2015
| Under COPD | Posted by
| 14 Comments
copdawarenessmonth

National COPD Month 

There are a number of initiatives during the year that are worthy of drawing our attention. One such occurrence is National COPD Awareness Month. That is why throughout the month of November, the Lung Institute will be focusing on a series of blog posts dedicated to understanding anything and everything associated with chronic obstructive pulmonary disease (COPD).

This chronic disease is characterized by an obstruction of airflow into and out of the lungs that makes breathing very difficult for a millions of Americans. People suffering from COPD have trouble walking short distances and are especially susceptible to illnesses like pneumonia. Most patients also need supplemental oxygen support throughout the day. Sadly, there is no cure for COPD but treatment options are available to slow the progression of the disease and improve quality of life.

According to the American Lung Association, 24 million Americans currently suffer from COPD. The surprising fact is that only half of that number are actually diagnosed. Which is why throughout the month, we will be presenting a number of topics to inform you about the importance of COPD. Here are some the stories you can look forward to:

During National COPD Awareness Month, we encourage you  stay informed about this disease and share what you’ve learned with at least one person. Share your story below or comment on our social media channels.

If you or a loved one has been diagnosed with a lung disease and want to learn more about treatment options, please contact us or call 888-745-6697 today.

 

 

 

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.